Nishat Jahan

Ms. Nishat Jahan

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2019 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
NJNishat Jahan
Nishat Jahan
SASabrina Rahman Archie
Sabrina Rahman Archie
ASAbdullah Al Shoyaib
Abdullah Al Shoyaib
NKNadia Kabir
Nadia Kabir
KCKarmen Cheung
Karmen Cheung
Recent studies on vaccine delivery systems are exploring the possibility of replacing liquid vaccines with solid dose vaccines due to the many advantages that solid dose vaccines can offer. These include the prospect of a needle-free vaccine delivery system leading to better patient compliance, cold chain storage, less-trained vaccinators and fewer chances for needle stick injury hazards. Some studies also indicate that vaccines in a solid dosage form can result in a higher level of immunogenicity compared to the liquid form, thus providing a dose-sparing effect. This review outlines the different approaches in solid vaccine delivery using various routes of administration including, oral, pulmonary, intranasal, buccal, sublingual, and transdermal routes. The various techniques and their current advancements will provide a knowledge base for future work to be carried out in this arena.

11 October 2021 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
NJNishat Jahan
Nishat Jahan
FRFahad Imtiaz Rahman
Fahad Imtiaz Rahman
PSPoushali Saha
Poushali Saha
SESadia Afruz Ether
Sadia Afruz Ether
ARAsm Roknuzzaman
Asm Roknuzzaman
NANur Haque Alam
Nur Haque Alam
In response to the raging COVID-19 pandemic, Bangladesh started its vaccine administration in early 2021; however, due to the rapid development and launch of the vaccines in the market, many people had concerns regarding the safety of these vaccines. The purpose of this study was to evaluate the side effects that were experienced by the Bangladeshi residents after receiving the first dose of the Oxford-AstraZeneca’s Covishield vaccine (ChAdOx1nCoV-19). The study was conducted using both online and printed questionnaires and the data were analysed using SPSS. The results included the responses of 474 vaccine recipients from March–April 2021. Pain at the site of injection, fever, myalgia, fatigue and headache were the most commonly reported symptoms, and the overall side effects were found to be significantly more prevalent in the younger population (p ≤ 0.05). These findings were consistent with the results indicated by the clinical trial of ChAdOx1nCoV-19. Logistic regression analysis further revealed that compared to people aged 70 years or above, the incidence of reported side effects was significantly higher in people aged 18–30 years (odds ratio (OR) = 8.56), 31–40 years, (OR = 5.05), 41–50 years (OR = 4.08), 51–60 years (OR = 3.77) and 61–70 years (OR = 3.67). In addition, a significantly higher percentage of female participants suffered from post-vaccination side effects compared to males (OR = 1.51). It was concluded that the Covishield vaccine was well-tolerated among people of different age groups. Nevertheless, further long-term follow-up study with a larger sample size is warranted to establish the long-term safety of the COVID-19 vaccine.

12 December 2019 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
NANur H. Alam
Nur H. Alam
HAHasan Ashraf
Hasan Ashraf
TATahmeed Ahmed
Tahmeed Ahmed
NJNishat Jahan
Nishat Jahan
NGNiklaus Gyr
Niklaus Gyr

27 March 2021 in Journal of Pharmaceutical Research International
Verified
Journal Article
Closed access
PDF file
RFRosy Fatema
Rosy Fatema
SKSumaiya Khan
Sumaiya Khan
ARA. S. M. Roknuzzaman
A. S. M. Roknuzzaman
RARamisa Anjum
Ramisa Anjum
NJNishat Jahan
Nishat Jahan
Loratadine, a second generation H1-receptor antagonist, works by blocking the action of histamine and is widely prescribed for itching, runny nose, watery eyes, and sneezing from "hay fever" and other allergic conditions. To ensure quality the main requirements for a medicinal product are safety, potency, efficacy and stability. This research work aimed to compare and assess the quality levels of different local brands of loratadine tablets available in the drug market of Bangladesh. Six different brands of loratadine 10 mg tablet manufactured by the local companies were used for the analysis. The evaluation was performed through the determination of weight variation, hardness, friability, percent potency, disintegration time, and dissolution profile in accordance with USP-NF specifications. All brands showed acceptable weight variation and % friability. The percent potency for tested samples by UV method ranges from 97.02%-108%, showing none of the brands contains less than 90% of the active principle as per the specification. The result of the physical and chemical studies, such as in-vitro dissolution, disintegration, hardness, etc., has been found to differ but lie within the specified limit. After analyzing the data obtained from the tests, it can be claimed that loratadine 10 mg tablets manufactured and marketed by several local companies in Bangladesh meet the quality standard required to achieve the desired therapeutic outcomes.

7 September 2020 in European Respiratory Journal
Verified
Conference Paper
Closed access
KMKazi Faisal Mahmud
Kazi Faisal Mahmud
KMKazi Raiyan Mahmud
Kazi Raiyan Mahmud
FZFatema Zannat
Fatema Zannat
MRMst Ruzina Rahman
Mst Ruzina Rahman
FRFatema Rafat
Fatema Rafat
NJNishat Jahan
Nishat Jahan
A qualitative studey was conducted in Dhaka, capital of Bangladesh. This included Key Informant Interview, In-Ieepth Interview and Focus group discussion with children having respiratory disorders ( mainly childhood asthma and chronic bronchitis and their parents and other members of the family. Overall findings include Children feels offended and are not ready to accept the advices from the clinicians, as they feel that these are imposed on them. As they are very much interested and engaged with cell phones/ table and mobile games - mobile games with adventures and having information on do9s, dont9s in an entertaining manner attracts them. They can relate well with their own life and understand the logic behind clinicians9 advice and accordingly through the game it is easier to increases knowledge, attitude and positive behaviors of children to combat respiratory disorders. Parents and other family members can also learn important information and their role from the games. Parents also feel that children will somehow be involved with cell phones/ will play mobile games. It is better if they have options to access such games which is not only adventurous but also entertaining and engaging will significantly benefit their children. Mobile games can also be important attain support and positive attitude from other family members. Conclusion: Mobile game can be an informal clinical tool which should include different level for the children themselves, parents and other family members. This can also be an important tool to organize community sessions, peer counseling, child to child and child to parent education at different social and geographic set up.